NBIX earnings date and history (2026)
Neurocrine Biosciences Inc. (NBIX) next reports earnings on Tue Oct 27. Analysts expect EPS of $1.99 (7 estimates), against $2.04 in the same quarter a year ago. Last time, on Thu Jul 30, it reported $2.36 against a $1.88 consensus (+25.5%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Jul 30, 2026 | $1.88 | $2.36 | — |
| May 5, 2026 | $1.28 | $1.41 | — |
| Feb 11, 2026 | $1.78 | $1.43 | — |
| Oct 28, 2025 | $1.58 | $2.04 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does NBIX report earnings?
- NBIX is scheduled to report on Tue Oct 27, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from NBIX?
- The consensus estimate is $1.99 a share across 7 analysts; the same quarter a year ago came in at $2.04.
- Did NBIX beat earnings last quarter?
- Yes: on Thu Jul 30 NBIX reported $2.36 against a $1.88 consensus, a +25.5% surprise.